Xeris Biopharma Holdings Inc (XERS)
Short-Term Debt
$70.09M
Quarterly · Period ending: · USD
XERS Short-Term Debt
Latest reported$70.09Mperiod ending
Latest reported$70.09Mperiod ending
XERS Quarterly Short-Term Debt ($0.00 → $70.09M)
Quarterly short-term debt
High-resolution chart · PNG
XERS short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 70,093,000 | |
| 6,271,000 | |
| 6,232,000 | |
| 6,194,000 | |
| 6,156,000 | |
| 18,076,000 | |
| 21,182,000 | |
| 21,099,000 | |
| 5,307,000 | |
| 4,624,000 | |
| 3,495,000 | |
| 2,366,000 | |
| 1,935,000 | |
| 1,448,000 | |
| 1,580,000 | |
| 0 | |
| 0 | |
| 341,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 3,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |